Ruben Mesa, MD from UT Health San Antonio Cancer Center discusses Pegylated Interferon Alfa-2a and the utilization of Interferon on patients with MPN is still limited at the 2017 American Society of Hematology.
Pegylated Interferon Alfa-2a – Utilization of Interferon on patients with MPN is still limited
